Authors


Qiaoyi Zhang, MD, PhD

Latest:

Compliance and Persistence With Concomitant Statin and Oral Antihyperglycemic Therapy

In patients with type 2 diabetes, compliance and persistence were generally low for both statin and antihyperglycemic therapy, but they were significantly lower with statin therapy.


Kateryna Fonkych, PhD

Latest:

Medicare HMO Impact on Utilization at the End of Life

HMOs in California, particularly Kaiser, have developed approaches to end-of-life care that allow them to use far fewer inpatient resources than fee-for-service providers.


Michael Deminski, MS, BSPharm

Latest:

Healthcare Professionals’ Perceptions of Challenges to Chronic Pain Management

Healthcare professionals report pain management barriers across system, provider, and patient levels, highlighting the need to consider chronic pain as a chronic condition that warrants coordinated approaches.


Baorong Yu, PhD

Latest:

Full Coverage for Hypertension Drugs in Rural Communities in China

Low-income rural residents receiving hypertension drugs at no charge had enhanced medication adherence and reduced medical costs in China.



Eric A. Vance, PhD

Latest:

Computed Tomography Scan Use Variation: Patient, Hospital, and Geographic Factors

We observed small-area variation in computed tomography scan use for inpatients in New York State, even after controlling for relevant patient and hospital characteristics.


William M. Vollmer, PhD

Latest:

Improving Adherence to Cardiovascular Disease Medications With Information Technology

Improving adherence to long-term medication therapy remains a challenge. Health information technology interventions that leverage electronic medical records are promising, low-cost approaches for increasing adherence.






Anna S. Purdum, PharmD, MS

Latest:

Step-Up Care Improves Impairment in Uncontrolled Asthma: An Administrative Data Study

Significant clinically meaningful improvements in asthma impairment are documented by administrative data for 1 year after initiation of step-up care in patients with uncontrolled asthma.


Robert A. Malmstrom, PharmD

Latest:

Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients

Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL.



Anne P. Ehlers, MD, MPH

Latest:

Use of Patient-Reported Outcomes and Satisfaction for Quality Assessments

Understanding the relationships among patient-reported outcomes, satisfaction, and quality is the first step in drawing meaningful conclusions that can then be translated into policy.




Katherine Upshur, MSW, LCSW

Latest:

The MS Center of Saint Louis: A Practice Perspective of the Impacts of High Cost Sharing

This case study from the MS Center of Saint Louis examines how patients are impacted by high healthcare costs and addresses potential solutions to this problem.




Amanda J. Abraham, PhD

Latest:

Deaths Among Opioid Users: Impact of Potential Inappropriate Prescribing Practices

Inappropriate prescribing practices of opioids are a major risk factor for mortality among opioid users in the Georgia Medicaid population, although risk is lower in managed Medicaid.


Walter J. Jones, PhD

Latest:

Medicaid Managed Care Reduces Readmissions for Youths With Type 1 Diabetes

An analysis of the largest cohort available reveals that youths with type 1 diabetes, on a Medicaid managed care plan, are less likely to be readmitted within 90 days of discharge.



Jennifer L. Wiler, MD, MBA

Latest:

Creating Successful Alternative Payment Models

The authors draw on the experience of past and present payment reforms to suggest principles for successfully designing alternative payment models.




Onchee Yu, MS

Latest:

Patient-Centered Medical Home Demonstration: A Prospective, Quasi-Experimental, Before and After Evaluation

A 12-month evaluation of a patient-centered medical home demonstration indicated improvement in quality of care without an increase in overall costs.




Ian M. Breunig, PhD

Latest:

Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients

Substantive outcome improvement and savings to Medicaid may be achieved with small changes in prescribing rates or comorbidity prevalence among patients with heart failure.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo